The chimeric transcription factor E2a-Pbx1 is expressed as a result of the 1;19 chromosomal translocation in some 5% of cases of pediatric acute lymphoblastic leukemia. We investigated the biological and transcriptional consequences of forced expression of E2a-Pbx1 in the interleukin-3 (IL-3) dependent, bone marrow-derived cell line Ba/F3. We show that forced expression of E2a-Pbx1 induces apoptosis in Ba/F3 cells without apparent effects on cell cycle progression. This pro-apoptotic effect is enhanced on cytokine deprivation. Furthermore, using cDNA representational difference analysis (RDA), we show that these cellular effects are associated with marked induction of the gene NDRG1, which was previously identified as a target of transcriptional repression by N-myc and induction by the tumor suppressor protein p53. We identify a portion of the NDRG1 promoter capable of mediating transcriptional induction by E2a-Pbx1 and show that NDRG1 is also induced on simple IL-3 deprivation of BaF3 cells. Although we show that E2a-Pbx1 induction of NDRG1 is not impaired as a result of targeting p53 using HPV E6, and therefore does not appear to be p53-dependent, our results overall are consistent with the notion that induction of NDRG1 by E2a-Pbx1 may represent part of an apoptotic or cytostatic cellular response to oncogene activation. Leukemia (2001) 15, 362-370.
Introduction
In roughly 5% of cases of pediatric acute lymphoblastic leukemia (ALL), a somatic chromosomal translocation results in the juxtaposition of 5′ elements from the gene E2A, on chromosome 19, with a large portion of the gene PBX1, on chromosome 1. In this manner, t(1;19) creates a fusion gene, E2A-PBX1, that encodes a chimeric transcription factor protein, E2a-Pbx1. 1 The products of E2A belong to a large family of transcription factors defined by the presence of a basic helix-loop-helix (bHLH) module. Whereas the two amphipathic helices within the bHLH mediate homo-or heterodimerization with other HLH-containing proteins, the adjacent group of basic amino acids mediates sequence-specific binding to DNA. 2 Alternative splicing of the E2a transcript leads to the expression of two proteins, E12 and E47, that differ minimally, exclusively within the bHLH domain. Mapping studies in which portions of E2a have been fused with heterologous DNA binding domains have defined two, separable transcriptional activation domains called AD1 and AD2. 3, 4 Mice targeted for E2A are completely devoid of B-lymphocytes, manifest profoundly disordered T-lymphopoiesis, and tend to develop T-lineage lymphoid neoplasms. [5] [6] [7] It encodes the proteins Pbx1a (long form) and Pbx1b (short form), which are generated through alternative pre-mRNA splicing. Pbx1 contains a homeodomain, a DNA binding module that, like the bHLH, defines a large family of transcription factor proteins. 8 The affinity and sequence specificity of DNA binding by Pbx1 are markedly enhanced through cooperative interactions with Hox proteins, a large subfamily of homeodomain-containing proteins with critical roles in determining segment identity during embryonic development. [9] [10] [11] Gene targeting of PBX1 in mice is associated with embryonic lethality and homeotic developmental abnormalities despite unperturbed expression levels of key Hox proteins. 12 Therefore, the currently available evidence supports a model in which Pbx1, by modulating DNA binding by Hox proteins, serves as a cofactor in the transcriptional regulation of developmentally important target genes.
E2a-Pbx1 is capable of inducing neoplastic transformation in several experimental assays. [13] [14] [15] It contains the N-terminal two thirds of E2a, including the two transcriptional activation domains, and most of Pbx1, including the DNA binding homeodomain. 1 These structural features and some functional data support a model in which E2a-Pbx1 contributes to neoplastic transformation through disrupting mechanisms that normally regulate the transcription of particular genes. Consistent with this notion, E2a-Pbx1 can induce the transcription of reporter constructs bearing Pbx1 binding elements, or of several endogenous genes identified with the use of differential cloning strategies in fibroblasts or lymphoid cells. [16] [17] [18] [19] [20] [21] Here, we have characterized the cellular and molecular consequences of enforced expression of E2a-Pbx1 in the interleukin-3 (IL-3) dependent, bone marrow-derived cell line Ba/F3. E2a-Pbx1 enhances the tendency of Ba/F3 cells to undergo apoptotic death, particularly in the presence of suboptimal concentrations of IL-3, without consistent effects on cell cycle progression. Using the differential cloning technique of cDNA representational difference analysis (RDA), we have demonstrated marked induction of the gene NDRG1 downstream of E2a-Pbx1. We demonstrate that DNA regulatory elements derived from the NDRG1 promoter can mediate reporter gene induction by E2a-Pbx1, suggesting that induction appears to occur, at least in part, at the transcriptional level. NDRG1 is transcriptionally repressed downstream of NMyc and is a known target of transcriptional induction by the tumor suppressor protein p53. However, we show that NDRG1 induction by E2a-Pbx1 appears to be p53-independent. In aggregate, our results are most consistent with a scenario in which NDGR1 induction by E2a-Pbx1 occurs through indirect mechanisms as part of a cellular response to oncogene activation.
Materials and methods

Cell lines, tissue culture, expression constructs and transfections
Ba/F3 cells (a kind gift of Dr Gerald Krystal, Terry Fox Laboratory, University of British Columbia) were propagated in RPMI containing 10% fetal bovine serum (FBS) and either 5 ng/ml of recombinant murine IL-3 (Sigma-Aldrich Canada, Oakville, ON, Canada) or 5% WEHI-3B-conditioned medium. cDNAs for expression in Ba/F3 cells were cloned using standard techniques into the plasmid pMT-CB6+ (a kind gift of Dr Frank Rauscher III, The Wistar Institute), which confers expression in mammalian cells regulated by a sheep metallothionein promoter and carries NEO as a selectable marker. 22 For transfections, 3 × 10 6 Ba/F3 cells in 400 l of complete medium containing 20 g of DNA were placed in an electroporation cuvette (gap 0.4 cm) and subjected to an electrical pulse (300 V, 1050 F) using a Gene Pulser II apparatus (BioRad Laboratories Canada, Mississauga, ON). Stably-transfected populations were selected by propagation for 10 days in medium containing 450 g/ml of G418, which was added after 24 h of growth in non-selective medium. Stable transfectants were generally analyzed as uncloned populations. In the transient transfection of luciferase reporter constructs, electroporation cocktails contained 4 g of expression plasmid, 10 g of luciferase reporter, 1 g of ␤-galactosidase-expressing construct and 5 g of pBluescript plasmid DNA. Luciferase and ␤-galactosidase assays were carried out 24 h after electroporation using chemiluminescence reagents (Tropix Inc, Bedford, MA, USA) according to instructions. For retroviral transduction of E6, NX-Eco retroviral packaging cells (kindly provided by Dr Gary Nolan, Stanford University) were transfected with pBabePuroE6 plasmid DNA (kindly provided by Dr Gordon Peters, Imperial Cancer Research Fund, London, UK) using a standard CaPO 4 protocol. Roughly 16 h later, the transfection medium was replaced with 6 ml of RPMI containing 10% FBS and 10 5 exponentially growing Ba/F3 cells that had been stably transfected with zinc-inducible E2a-Pbx1a. After 2 days of co-culture, the Ba/F3 cells were separated from the adherent packaging cells by gentle pipetting and subjected to selection in puromycin (1 g/ml) for 10 days.
Cell cycle and apoptosis assays
For experiments involving IL-3 deprivation, cells were washed three times in RPMI without IL-3 before resuspension in medium containing IL-3 at the specified concentrations. In order to enumerate Ba/F3 cells in the various phases of the cell cycle, cells were labeled by adding 5-bromodeoxyuridine (BrdU, Roche Diagnostics, Laval, Canada) to 0.02 nm in the culture medium for 25 min, washed in phosphate-buffered saline (PBS) and fixed in 70% ethanol. Cells were then washed twice in PBS, resuspended in 1 ml of 1 N HCl containing 0.5% Triton X-100 and incubated for 30 min at 37°C. Cells were washed three times in PBS, resuspended in 50 l of blocking solution (3% BSA and 0.5% Triton X-100 in PBS) containing 5 g/ml of mouse monoclonal anti-BrdU (Roche Diagnostics) and incubated for 1 h at room temperature. Cells were then washed, incubated with a FITC-conjugated, goat anti-mouse secondary antibody, washed and resuspended in 1 ml of PBS containing 10 g/ml propidium iodide (PI), 0.5 mg/ml RNAse A, 0.1% NP 40, and 0.1% trisodium citrate.
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Fluorescence signals from FITC and PI were then correlated using an EPICS Elite flow cytometer.
To semi-quantify apoptosis using the DNA fragmentation assay, 1 × 10 6 viable-appearing cells were pelleted and fixed in 70% ethanol. Cells were washed once with PBS then incubated for 30 min in 40 l of a solution containing 0.1 m sodium citrate and 0.2 m sodium phosphate to extract fragmented DNA from cells. Cells were then pelleted and the DNA contained in 10 l of the supernatant was fractionated on a 1.5% agarose gel. The TUNEL assay was performed using a commercial kit (APO-BRDU, Pheonix Flow Technologies, San Diego, CA, USA) according to the manufacturer's instructions.
cDNA representational difference analysis RDA was performed as described previously using polyA+ RNA purified from 10 7 cells. 23 The second difference products (DP-2) were separated on a 2% agarose gel, recovered from agarose and subcloned into the BamHI site of pBluescript.
Western and Northern blots
For the evaluation of protein expression by immunoblotting, cells were lysed in 70 l of protein sample buffer and boiled. Fifteen micrograms of protein from each sample was fractionated on a discontinuous polyacrylamide gel under denaturing conditions and transferred electrophoretically to a nitrocellulose membrane. The membrane was blocked overnight in PBS containing 5% nonfat dried milk and 0.1% Tween 20 and then subjected sequentially to an overnight incubation with the primary monoclonal antibody, three 5-min washes in PBS/Tween, and a 1 h incubation with horseradish peroxidase-conjugated, anti-mouse secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). After a final wash, secondary antibody on the membrane was detected by autoradiography using chemiluminescence reagents (NEN Life Science Products, Boston, MA, USA) according to the manufacturer's instructions. E2a-Pbx1 was detected using the Yae monclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a 1:1000 dilution and p53 was detected using the Ab-3 monoclonal antibody (Oncogene Science, Cambridge, MA, USA) at a dilution of 1:200 from the stock solution.
For Northern blots, total RNA was isolated using Trizol (Life Technologies, Rockville, MD, USA) according to the manufacturer's instructions. Fifteen micrograms of total RNA was fractionated by electrophoresis on a 1% agarose-formaldehyde gel, transferred to a Hybond-N+ membrane (Amersham Pharmacia Biotech, Piscataway, NJ, USA), and hybridized with a 32 P-labelled probe using standard methods. Signal intensity on the blots was quantified using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA, USA).
Results
E2a-Pbx1 promotes apoptosis in Ba/F3 cells
Ba/F3 cells were transfected with a plasmid that confers zincinducible expression of E2a-Pbx1a mediated by a sheep metallothionein promoter. Stably-transfected populations were selected in medium containing G418. Zinc-inducible expression of E2a-Pbx1 by transfectants was confirmed by immunoblot using an anti-E2a monoclonal antibody ( Figure 1 ). Subsequent experiments were done using uncloned transfectant cell populations, except for the experiment involving p53 inactivation, in which cloned cells were used.
We initially wished to evaluate potential effects of enforced E2a-Pbx1 expression on cell growth and viability. Growth curves indicated that expression of E2a-Pbx1 was associated with impaired cell accumulation relative to controls under optimal or IL-3-deficient conditions (Figure 2a ). These differences could be explained by either a reduced rate of cell division or accelerated cell death in E2a-Pbx1-expressing cells. To evaluate possible effects on cell cycle progression in zinc-induced transfectants, S-phase cells were labelled with bromodeoxyuridine (BrdU) and the resulting fluorescence signal was correlated with cellular DNA content using twodimensional flow cytometry ( Figure 2b ). As expected, IL-3 deprivation was associated with delayed progression through G1 in both E2a-Pbx1 transfectants and controls. However, forced expression of E2a-Pbx1 was associated with only minor, inconsistent differences in cell cycle parameters of uncertain significance. In order to evaluate possible effects of E2a-Pbx1 on apoptosis, stable transfectants were pre-incubated with zinc and then maintained for 24 h in the presence of decreasing concentrations of IL-3, supplied as WEHI-3B-conditioned medium. Internucleosomal degradation of DNA, a characteristic feature of apoptotic death in Ba/F3 cells, was then evaluated by agarose gel electrophoresis (Figure 2c ). Under optimal
Figure 1
Zinc-dependent expression of E2a-Pbx1a. A Western blot using an anti-E2a monoclonal antibody shows marked induction of E2a-Pbx1a expression on addition of zinc in stably transfected Ba/F3 cells. Expression is barely detectable in the uninduced state. The monoclonal antibody interacts minimally with endogenous, murine E2a proteins. growth conditions (complete medium containing 5% WEHI-3B supernatant), expression of E2a-Pbx1 was associated with a slight increase in DNA fragmentation. This preferential DNA fragmentation related to E2a-Pbx1 expression appeared greater when the concentration of IL-3 was reduced to 0.5 or 0.05%. Morphological evaluation indicated a three-fold greater proportion of apoptotic cells in E2a-Pbx1 transfectants relative to empty vector-transfected controls (64% vs 21%) after 24 h in medium containing 0.5% WEHI-3B-conditioned medium (data not shown). We infer from these data that E2a-Pbx1 increases the rate of apoptosis in Ba/F3 cells and increases their sensitivity to IL-3 deprivation.
E2a-Pbx1 induces expression of the gene NDRG1
In order to identify E2a-Pbx1-regulated genes whose expression might be altered in association with this pro-apoptotic effect, we applied cDNA RDA to uncloned populations of Ba/F3 cells. RNA was isolated from populations of cells stably transfected with E2a-Pbx1a, or 'empty' vector, after 24 h of zinc induction in medium containing a concentration of recombinant IL-3 sufficient to support proliferation and survival (5 ng/ml). When cDNA from cells transfected with empty vector was used as 'tester' and cDNA from E2a-Pbx1-expressing cells as 'driver' (ie to identify transcripts that may be repressed by E2a-Pbx1), no discrete bands were visible on gel electrophoresis of the second difference product (data not shown). However, when the subtraction was performed in the reverse direction, using cDNA from E2a-Pbx1-expressing cells as tester, five bands were resolved that ranged in size from roughly 200 to 600 bp ( Figure 3 ). These polymerase chain reaction (PCR) products were cloned into pBluescript (clones 1M, 2C, 2F, 3A, and 4) and sequenced. Searches of NCBI databases were performed with the resultant sequence data.
Clone 1M comprised a portion of the E2a-Pbx1a cDNA bracketed by DpnII sites at positions 1926 and 2549. This finding served to validate the differential cloning method. Clone 2C contained cDNA sequence of unknown function previously identified in a human BAC clone (GenBank accession No. AC004549). Clone 2F encoded a portion of elongation factor 2 (EF-2). Clone 3A comprised a portion of cDNA (positions 691 to 1036) from the gene Ndr1 (see below), and clone 4 represented a portion of 28S ribosomal RNA.
To evaluate differential expression induced by E2a-Pbx1, these cDNA fragments were used to probe Northern blots of RNA purified from the populations of stably-transfected Ba/F3 cells ( Figure 3 ). As expected, probing with the insert from clone 1M produced an intense signal in the roughly 3 kb range on zinc induction of E2a-Pbx1 transfectants (lane 4). We surmise that a weaker, higher molecular weight signal detected in uninduced cells (lane 2) was likely the result of low-level transcription from a constitutive promoter located more 5′ on the expression vector. Probing with clone 2F confirmed constitutive expression of EF-2. Probing with clone 3A revealed a roughly 3 kb transcript of Ndr1 that was present exclusively in those Ba/F3 cells that had been transfected with E2a-Pbx1 and induced with zinc (lane 12). No signal was observed on probing with clone 2C and expression of clone 4 (28S rRNA) was constitutive, as expected (data not shown).
Ndr1 is the murine homolog of human RTP, and the two genes encode predicted proteins with 93% identity. RTP is widely expressed in tissues and encodes a protein of M r 43 000 with no recognizable functional motifs other than sev- eral predicted phosphorylation sites, a putative phosphopentetheine attachment site, and a previously undescribed 10 amino acid motif that is repeated three times near the C-terminus. It was first identified as a transcript induced in human endothelial (HUVEC) cells on treatment with homocysteine. 24 Subsequently, a number of groups have reported differential expression of this gene in diverse cell types in response to diverse stimuli, leading to the acquisition by a single gene of a confusing multitude of names, including Drg1, Cap43, and RTP/rit42. Expression of RTP is induced on differentiation of colon carcinoma cell lines, or on exposure of a variety of cell types to nickel-containing compounds. 25, 26 Lower expression has been observed in neoplastic cell lines of several lineages relative to their non-neoplastic counterparts. 27 Of perhaps greatest relevance to the work described here, RTP is induced downstream of the tumor suppressor p53 in several cell types Leukemia and may mediate some of p53's cytostatic effects, including negative effects on cell proliferation, anchorage-independent growth and tumorigenicity in nude mice. 27, 28 Recently, two of us (TO and HK) reported that Ndr1, the mouse homolog, is transcriptionally repressed downstream of the nuclear oncoprotein N-myc. 29 An agreement was reached recently to refer to both the murine and human genes as NDRG1. TDD5, a mouse gene highly identical to murine NDRG1 and possibly representing an alternative splice product, is transcriptionally repressed in response to testosterone. 30 Considering the regulatory relationship that appears to exist between murine NDRG1 and N-myc, the previously demonstrated association of human NDRG1 expression with cellular differentiation, cell cycle arrest and apoptosis, and the evidence implicating human NDRG1 as a downstream effector of some p53 functions, we elected to investigate further the relationship between E2a-Pbx1 and NDRG1.
Cis-acting 5′ regulatory elements related to NDRG1 can mediate transcriptional induction by E2a-Pbx1
We investigated the possiblity that induction of NDRG1 downstream of E2a-Pbx1 might be mediated through cis-acting DNA elements associated with the NDRG1 promoter. Ba/F3 cells were transiently co-transfected with a plasmid conferring constitutive expression of E2a-Pbx1a mediated by the CMV promoter along with reporter plasmids in which expression of firefly luciferase was regulated by various portions of 5′ genomic DNA associated with the murine NDRG1 promoter (Figure 4) . The complete sequence of this promoter Induction of the NDRG1 promoter by E2a-Pbx1a. Transient co-transfection of Ba/F3 cells with E2a-Pbx1a and luciferase reporter constructs containing 5′ genomic DNA sequence related to murine NDRG1 indicate that induction of NDRG1 by E2a-Pbx1 can be mediated by a small promoter segment that includes an Sp1 consensus recognition sequence and the TATA box.
region, from nucleotide positions −637 to +194 relative to the transcriptional start site, is provided elsewhere. 29 In these experiments, a relatively small portion of 5′ DNA beginning at nucleotide position −52 was associated with maximal luciferase activity, suggesting that silencing elements may exist further 5′. This small DNA fragment also conferred nearmaximal, 21-fold responsiveness to E2a-Pbx1. Deletion from this fragment of an additional 19 nucleotides resulting in the removal of a predicted Sp1 binding site immediately 5′ to the TATA box led to a marked reduction in both absolute luciferase expression levels and responsiveness to E2a-Pbx1. Deletion of the TATA box was associated with a further marked decrease in both luciferase activity and E2a-Pbx1 responsiveness (data not shown). Inspection of the nucleotide sequence from position −52 failed to uncover a predicted binding site for Pbx1 or a Pbx1-Hox heterodimer. This absence of apparent Pbx1 binding sites within a restricted region of DNA capable of mediating induction by E2a-Pbx1 suggests that the regulatory relationship that exists between E2a-Pbx1 and NDRG1 may be indirect, perhaps involving additional, intermediary proteins.
A time course experiment indicated that while expression of recombinant E2a-Pbx1a protein was near-maximal by 6 h after induction with zinc, the abundance of the NDRG1 transcript underwent a sharp increase between 12 and 15 h postinduction ( Figure 5 ). This suggests a latency period of roughly 9 h between the onset of elevated levels of E2a-Pbx1 protein and the consequent accumulation of NDRG1 transcript. Quantitative evaluation of signal intensity by Phosphorimager indicated a 27-fold induction of NDRG1 by 24 h ( Figure 5) . As in all quantitative determinations in this study using Northern blots, values for NDRG1 signal were normalized by stripping the membrane and re-probing for the housekeeping transcript G3PDH. The relatively long latency between the upsurge in E2a-Pbx1 levels and induction of NDRG1 is consistent with the existence of an indirect regulatory relationship between these two events.
The ability of E2a-Pbx1 to induce apoptosis in a B-ALL cell line has been shown previously to require the Pbx1 homeodomain. 31 To investigate the role of the Pbx1 homeodomain in induction of NDRG1, Ba/F3 cells were stably transfected with a plasmid conferring zinc-inducible expression of the protein E2a-Pbx1⌬HD, which contains a targeted deletion of the Pbx1 homeodomain (amino acids 627-689 in E2a-Pbx1a). In two experiments, this protein failed consistently to induce the expression of NDRG1 (Figure 6, compare lanes 9-12 with  lanes 5-8) . This observation suggests that, as with its pro-
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Figure 5
Time course of NDRG1 induction downstream of E2a-Pbx1a. A population of stably-transfected Ba/F3 cells was induced with zinc and subsequent expression levels of E2a-Pbx1a protein and NDRG1 transcript were followed using Western (upper image) or Northern blots (middle image), respectively. The graph compares foldinduction of NDRG1 transcript in E2a-Pbx1a-transfected (solid circles) and empty vector-transfected (open circles) populations of Ba/F3 cells. Quantification was by Phosphorimager and all values were normalized to those obtained on reprobing of the blots for G3PDH. apoptotic effect, E2a-Pbx1 must function as a DNA-binding transcription factor in the induction of NDRG1. Also observed consistently in several experiments was a relative induction of NDRG1 on IL-3 deprivation of empty vector-transfected Ba/F3 cells, albeit to lower levels than those seen in association with E2a-Pbx1 ( Figure 6, lanes 1-4) . This observation lends support to the existence of a functional relationship between NDRG1 and apoptosis.
Induction of NDRG1 downstream of E2a-Pbx1 does not require p53
Human NDRG1 is a target of transcriptional induction by p53 and has been said to play some role in mediating p53's antiproliferative effects. 27 The p53 protein can be functionally induced by diverse stimuli, including oncogene activation and growth factor deprivation. Therefore, we considered the possibility that p53 might function as an intermediary in the induction of NDRG1 downstream of E2a-Pbx1. A clone of stably E2a-Pbx1-transfected Ba/F3 cells was infected with a retroviral vector conferring expression of the human papilloma virus (HPV) protein E6, which mediates inactivation and destruction of p53. 32 An anti-p53 immunoblot confirmed that retroviral transduction of E6 markedly attenuated the enhanced accumulation of p53 protein that normally occurs on irradiation of Ba/F3 cells (Figure 7a) . 33 A Northern blot of RNA purified 26 h after zinc induction of E2a-Pbx1 indicated persistence of a modest increase in NDRG1 expression irrespective of the presence of E6 (Figure 7b ). The magnitude of NDRG1 induction in this clone was considerably less than that observed earlier in the uncloned BaF3 cell population. We speculate that this may be related to clonal variation. Nonetheless, these results indicate that activation of p53 is not required in the induction of NDRG1 downstream of E2a-Pbx1.
In order to investigate the potential relevance to human leukemia of NDRG1 induction by E2a-Pbx1, we next evaluated expression of human NDRG1 by Northern blot in human ALL cell lines (Figure 8 ). The Reh cell line is derived from a case of B-lineage ALL. Raji is derived from Burkitt's lymphoma, a neoplasm with phenotypic features of fully differentiated B cells. UOCB1 is derived from B-lineage ALL and is associated with expression of endogenous E2a-Hlf, a chimeric, leukemogenic transcription factor expressed in a small proportion of pediatric ALL cases. The B-lineage ALL lines 697 and RCH ACV are associated with t(1;19) and express endogenous E2a-Pbx1. Finally, the lines LB-1, -2, -3, -4 and -5 are lymphoblastoid lines established by immortalizing B cells from normal donors using Epstein-Barr virus. The Northern blot indicated elevated expression of NDRG1 in the three lines derived from immature B-lineage progenitor cells that express endogenous E2a-fusion proteins (UOCB1, 697 and RCH ACV).
Discussion
Several observations in our study suggest that the regulatory relationship between E2a-Pbx1 and NDRG1 may be indirect. These include the relatively long latency of induction and the absence of apparent Pbx1 binding elements in the murine NDRG1 promoter. Therefore, we considered the possibility that induction could require the intercession of other factors.
A tumor suppressor protein mutated in greater that 50% of human cancers, wild-type p53 can induce cell cycle arrest or apoptosis in response to diverse stimuli, including DNA damage or oncogene activation. 34 Perhaps most compelling in considering the possibility of a relationship between NDRG1 function and neoplastic transformation are data implicating NDRG1 as a target of induction by p53 and a downstream mediator of p53-dependent, anti-oncogenic functions. 27 These considerations led us to ask whether p53 could function downstream of E2a-Pbx1 in the induction of NDRG1, and whether NDRG1, in turn, could contribute to the pro-apoptotic effect associated with E2a-Pbx1 expression in Ba/F3 cells.
In our study, antagonizing p53 with HPV E6 failed to impair NDRG1 induction by E2a-Pbx1. In a recent study using serial analysis of gene expression (SAGE) to survey transcriptional target genes of p53, NDRG1 emerged as one of six p53-inducible genes that could also be induced by p73, a p53 homolog not targeted by E6. 28, 35 Furthermore, although NDRG1 expression can be induced by DNA damaging agents in several cell lines, this induction does not invariably require p53. 28 These results lend further support to the highly plausible notion that multiple mechanisms exist for the induction of NDRG1 expression. Therefore, although our results with E6 argue against a requirement for p53 in NDRG1 induction by E2a-Pbx1, they do not exclude the possibility that NDRG1 could be induced by other means as part of an apoptotic or cytostatic cellular response to oncogene activation. This idea is consistent with the previous observation that E2a-Pbx1-induced apoptosis is not dependent on functional p53. 31 Exposure of prostatic adenocarcinoma cells to androgen, colonic adenocarcinoma cells to low glucose concentration, myelomonocytic leukemia cells to retinoic acid or vitamin D 3 , or trophoblastic cells to forskolin induces NDRG1 expression in association with cellular differentiation and cell cycle arrest. 25, [36] [37] [38] [39] Furthermore, endogenous expression of murine NDRG1 correlates with tissue differentiation in embryonic tissues and is repressed downstream of the nuclear oncoprotein N-myc. 29 Since terminal differentiation is associated with apoptosis in many cell types, including epithelial and myeloid lineages, the association of NDRG1 expression with cellular differentiation is also consistent with a role in apoptosis. Also supportive of such a role has been the demonstration in primary human samples of preferential NDRG1 expression in tissues in which apoptosis appears to play a particularly important regulatory role, including periluminal, surface colonic epithelium and placental trophoblast. 25, 40, 41 We did not observe cytostatic effects on forced expression of recombinant murine NDRG1 in Ba/F3 cells (data not shown). However, evaluation by Northern blot showed that the expression level of recombinant NDRG1 was considerably lower than that of the endogenous gene in response to E2a-Pbx1 (data not shown), making our failure to observe phenotypic changes difficult to interpret.
Two of us (TO and HK) have shown previously that expression of NDRG1 is repressed downstream of N-myc. 29 Therefore, in considering possible intermediary factors, we wondered whether the effects of E2a-Pbx1 on NDRG1 expression might be mediated through repression of myc famLeukemia ily members. Alternatively, since enforced expression of Nmyc can induce apoptosis under certain conditions, we considered the possibility that the pro-apoptotic effects of E2a-Pbx1 might correlate with myc induction. However, evaluation by Northern blot failed to uncover any effect of enforced E2a-Pbx1 expression on the abundance of N-myc or C-myc transcripts (data not shown). Therefore, it appears that the regulation of NDRG1 transcription may be mediated through either myc-dependent or myc-independent pathways, and that regulation downstream of E2a-Pbx1 involves one of the latter.
The short portion of 5′ genomic DNA sequence from the murine NDRG1 locus capable of mediating transcriptional induction by E2a-Pbx1 contains a predicted Sp1 binding element, raising the possibility that NDRG1 induction could be mediated by Sp1 or related proteins. Sp1 belongs to a family of closely related transcription factors with at least 16 members in mammals. 42 Although relative binding affinities vary, these proteins recognize very similar sites on DNA. Furthermore, their transcriptional functions appear to be regulated, to a considerable degree, by such factors as relative expression levels of several family member proteins and posttranslational modifications, including phosphorylation. We chose not to pursue experimentally the possibility that Sp1-related transcription factors could mediate NDRG1 induction. Nonetheless, the idea remains plausible.
In summary, we have shown that forced expression of E2a-Pbx1 induces apoptosis in Ba/F3 cells associated with induction of the gene NDRG1. NDRG1 is a target of transcriptional induction by p53 and a putative mediator of some anti-proliferative effects. Although induction of NDRG1 consequent to E2a-Pbx1 expression does not require the intercession of p53 in BaF3 cells, it remains likely that NDRG1 induction represents part of a cytostatic or apoptotic cellular response to oncogene activation.
